Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: Correlation with Jab1 stability and PI3K/Akt pathway

Experimental and Molecular Pathology

Volumn 97, Issue 2, 2014, Pages 191-201

  Wang, Hua ^a   Liu, Xiao Bing ^a   Chen, Jia Hui ^a   Wang, Qing Qing ^a   Chen, Jin Peng ^a   Xu, Jun Fei ^a   Sheng, Chen Yi ^a   Ni, Qi Chao ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Breast cancer; BRSK1; Jab1; PI3K Akt; Prognosis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BINDING PROTEIN; BRAIN SPECIFIC KINASE 1; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

BREAST CANCER; BRSK1; JAB1; PI3K/AKT; PROGNOSIS;

ADULT; BREAST NEOPLASMS; CARCINOMA; CHROMONES; CYTOPLASM; ENZYME STABILITY; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; MIDDLE AGED; MORPHOLINES; PEPTIDE HYDROLASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84905859756     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.07.012     Document Type: Article

References (24)

1. Alvarado-Kristensson M., et al. SADB phosphorylation of gamma-tubulin regulates centrosome duplication. Nat. Cell Biol. 2009, 11:1081-1092.
2. Barnes A.P., et al. LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 2007, 129:549-563.
3. Bright N.J., et al. Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. J. Biol. Chem. 2008, 283:14946-14954.
4. Chen X.Y., et al. Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic beta-cells. J. Biol. Chem. 2012, 287:30368-30375.
5. Chiarle R., et al. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res. 2001, 3:91-94.
6. Claret F.X., et al. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996, 383:453-457.
7. Fan D., et al. The molecular mechanisms that underlie the tumor suppressor function of LKB1. Acta Biochim. Biophys. Sin. 2009, 41:97-107.
8. Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol. Rep. 2004, 11:277-284.
9. Hsu M.C., et al. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr. Relat. Cancer 2007, 14:655-667.
10. Inoue E., et al. SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release. Neuron 2006, 50:261-275.
11. Ito Y., et al. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Anticancer Res. 2003, 23:4121-4125.
12. Kishi M., et al. Mammalian SAD kinases are required for neuronal polarization. Science 2005, 307:929-932.
13. Kouvaraki M.A., et al. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res. 2003, 63:2977-2981.
14. Lizcano J.M., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23:833-843.
15. Lu R., et al. Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function. J. Biol. Chem. 2004, 279:31164-31170.
16. Muller M., et al. Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and SadB-deficient neurons disrupts neuronal polarity. J. Cell Sci. 2010, 123:286-294.
17. Parkin D.M., et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
18. Ponder B.A. Cancer genetics. Nature 2001, 411:336-341.
19. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 1997, 3:222-225.
20. Shintani S., et al. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 2003, 65:355-362.
21. Sui L., et al. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin. Cancer Res. 2001, 7:4130-4135.
22. Wei N., et al. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol. 1998, 8:919-922.
23. Yang K.T., et al. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells. J. Cell. Physiol. 2011, 226:2849-2856.
24. Zhou J., et al. Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 2012, 422:647-652.